Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin - study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.

BMJ open（2022）

引用 0|浏览5

暂无评分

摘要

ACTRN12621001465842.

查看译文

关键词

COVID-19,IMMUNOLOGY,NUTRITION & DIETETICS,Renal transplantation,Transplant medicine,VIROLOGY

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要